<DOC>
	<DOC>NCT02783859</DOC>
	<brief_summary>An intervention study to determine if a longer duration of antibiotics (compared to shorter duration) improves the short and long term clinical outcomes of children hospitalised for pneumonia</brief_summary>
	<brief_title>Hospitalised Pneumonia With Extended Treatment (HOPE) Study</brief_title>
	<detailed_description>A multi-centre double-blind randomised controlled trial to determine if a longer duration of amoxicillin-clavulanic acid (compared to shorter duration) improves the short and long term clinical outcomes of children hospitalised with community-acquired pneumonia, in Indigenous children and a developing country</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<criteria>1. Hospitalised children aged 3mo to 5yrs (in Darwin, children have to be Indigenous) 2. Have features of severe pneumonia on admission (temperature &gt;37.5 celsius or a history of fever at home or observed at the referring clinic, ageadjusted tachypnoea [respiratory rate&gt;50 if &lt;12months; respiratory rate&gt;40 if &gt;12months] with chest wall recession and/or oxygen saturation &lt;92% in air), and consolidation on chest Xray as diagnosed by treating clinician 3. After 13 days of IV antibiotics, are afebrile, with improved respiratory symptoms and signs, oxygen saturation&gt;90% in air and are ready to be switched to oral amoxicillinclavulanate, and 4. Have symptoms of no longer than 7 days at point of hospitalisation. 1. Current wheeze 2. Underlying chronic illness other than asthma (e.g. bronchiectasis, cyanotic congenital heart disease or cardiac failure, neuromuscular disorders, immunodeficiency) that could potentially influence the current illness 3. Severe malnutrition (weightforheight Zscore &lt;3) 4. Complicated (effusion, empyema or abscess) pneumonia, including tuberculosis 5. Extrapulmonary infection requiring antibiotic therapy (e.g. meningitis) 6. Betalactam allergy 7. Previously enrolled 8. Lack a mobile phone and/or unable to return for followup clinic visits during the next 24 months</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Children</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
	<keyword>Indigenous Population</keyword>
	<keyword>Hospitals</keyword>
</DOC>